Homeopathic treatment of Diabetes

HPTLC Evaluation of Tinospora cordifolia Mother Tincture and Ascertaining its Effectiveness in Comparison to individualised Homeopathic Medicines in the Treatment of Type II Diabetes Mellitus: An Open Randomized Pragmatic Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/10/016197

Enrollment

Registered

2018-10-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Tinospora cordifolia mother tincture: Tinospora cordifolia mother tincture will be administered orally in personalised dosage (10-20 drops / once-thrice daily in half cup of normal wate

16 doses to be marked on the vial

each dose of 5 ml to be taken after 10 uniformly forceful downward strokes to the vial in 45 ml normal water in a clean cup, to stir well, to take 5 ml of this liquid orally, and to discard rest of th

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed cases of type II diabetes mellitus 2. Age 18-65 years 3. Both sexes 4. Ability to read English and/or Bengali 5. Capability and willingness to give informed consent and to comply with the study protocol

Exclusion criteria

Exclusion criteria: 1. Patients suffering from type I diabetes mellitus 2. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any vital organ failure 3. Substance abuse and/or dependence 4. Self-reported immune-compromised state 5. Undergoing homeopathic treatment for any chronic disease within last 6 months 6. Patients taking anti-diabetic medicines 7. Patients who are too sick for consultation, not willing to cooperate or denying consent to join the study 8. Pregnant women and lactating mothers

Design outcomes

Primary

Measure	Time frame
Fasting blood sugar, post-prandial blood sugar, and blood glycosylated hemoglobin (HbA1C) percentageTimepoint: At baseline and after 3 months	—

Secondary

Measure	Time frame
Blood lipid profile, plasma urea and creatinineTimepoint: At baseline and after 3 months;Diabetes Symptom Checklist Revised score (DSC-R)Timepoint: At baseline and after 3 months	—

Countries

India

Contacts

Public ContactDilip Panakadda

National Institute of Homoeopathy

drdilipan@gmail.com9038603007

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026